Drug Name |
Ambrisentan
|
||
Synonyms |
Letairis; Ambrisentan [INN]; Gilead brand of ambrisentan; BSF 208075; BSF208075; LU 208075; LU208075; BSF-208075; LU-208075; Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phe; (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; 2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
|
||
Drug Type |
Small molecular drug
|
||
Indications |
Pulmonary arterial hypertension [ICD-11: BB01.0]
|
Approved
|
|
Company |
GSK
|
||
Summary |
Ambrisentan is a selective type A endothelin receptor antagonist used to treat primary pulmonary arterial hypertension and pulmonary arterial hypertension based on diagnostic classifications.
|
||
Target |
Endothelin A receptor (EDNRA)
Mechanism of Action: Antagonist
|
T23499 |
![]() |
Formula |
C22H22N2O4
|
Canonical SMILES |
CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
|
|
InChI |
1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
|
|
InChIKey |
OUJTZYPIHDYQMC-LJQANCHMSA-N
|
|
CAS Number | CAS 177036-94-1 | |
TTD ID | D0X5ZI | |
DrugBank ID | DB06403 | |
PubChem Compound ID | 6918493 | |
PubChem Substance ID |
12015371
,
14779987
,
17194924
,
43529863
,
50551569
,
51091419
,
53787770
,
57371956
,
93309673
,
103307060
,
104035299
,
114788055
,
118855302
,
126616865
,
126651844
,
131302629
,
134338642
,
135692418
,
137237404
,
139988399
,
143497715
,
144205520
,
152133959
,
152238501
,
152258462
,
160647297
,
160826914
,
162011508
,
162172038
,
163093066
,
163387054
,
164824132
,
170465143
,
174007223
,
175267375
,
175426501
,
178100778
,
179116973
,
185986582
,
187071933
,
196107821
,
198977886
,
198991664
,
204430246
,
211534802
,
223375980
,
223532574
,
223704800
,
224518792
,
226395806
|
|
ChEBI ID | CHEBI:135949 | |
ADReCS Drug ID | BADD_D00100 |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |